Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
A Phase 3 Study of Relacorilant in Combination with Nab-Paclitaxel versus Nab-Paclitaxel Monotherapy in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tu
Sponsored by GOG Foundation, Inc.
Active
$560.9K Funding
3 People
External
Related Topics
ovarian cancer,
combination therapy,
platinum-resistant,
peritoneal cancer,
fallopian-tube cancer
People
Aradhana Kari
(CD)
Cancer Center Division
﹒Research Compliance Administrator II
Mitzi Miranda
(CD)
Cancer Center Division
﹒Research Program Administration Officer III
Setsuko Chambers
Principal Investigator (PI)
Obstetrics and Gynecology
﹒Professor
